Prehabilitation is feasible in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy and may minimize physical deterioration: results from The REx trial

S. J. Moug (Lead / Corresponding author), N. Mutrie, S. J. E. Barry, G. Mackay, R. J. C. Steele, C. Boachie, C. Buchan, A. S. Anderson

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)
155 Downloads (Pure)

Search results